Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study
Tsutomu Takeuchi(Keio University), Hisashi Yamanaka(Tokyo Women's Medical University), Kazuyoshi Saito(Iwate Medical University), Masao Nawata(Saitama Medical University), Kentaro Hanami(Saitama Medical University), Hideto Kameda(Toho University), Shunsuke Fukuyo(University of Occupational and Environmental Health Japan), Hayato Nagasawa(Saitama Medical University), Daisuke Hoshi(Saitama Medical University), Koichi Amano(Saitama Medical University), Takahiko Kurasawa(Saitama Medical University), Emília Inoue Sato(Universidade Federal de São Paulo), Yoko Kaneko(Keio University), Yoshiya Tanaka(University of Occupational and Environmental Health Japan)
Cited by 89
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
Trial of Anifrolumab in Active Systemic Lupus Erythematosus
|New England Journal of Medicine|2019|1.3k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913